Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study
Sponsor: CES University
A PHASE2/PHASE3 clinical study on Coronavirus and Coronavirus Infection, this trial is completed. The trial is conducted by CES University and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 2 earlier versions
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CES University
- Fundación Universitaria de Ciencias de la Salud
- Instituto Distrital de Ciencia Biotecnología e Innovacion en Salud
- Universidad del Rosario
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bogota, Colombia